Modivcare Inc Intrinsic Value Calculator – MODIVCARE INC Reports Earnings Results for Q4 of FY2022 as of December 31 2022
March 8, 2023
Earnings Overview
MODIVCARE INC ($NASDAQ:MODV) announced its financial results for the fourth quarter of FY2022, ending December 31, 2022, on February 23, 2023. Total revenue for the quarter was USD -7.0 million, a significant 78.0% increase compared to the same period in the preceding year.
Transcripts Simplified
MODIVCARE INC‘s fourth quarter revenue increased 14% year over year to $654 million. Net loss from continuing operations was $7 million or $0.49 cents per share. Adjusted net income for the fourth quarter of 2022 was approximately $30 million or $2.11 per diluted share. Fourth quarter adjusted EBITDA was approximately $60 million or 9.1% of revenue.
In the fourth quarter of 2022, NEMT revenue increased 14% year-over-year to $459 million, driven by a 16% increase in average monthly members. Service expense for the NEMT segment, which includes all direct costs, increased approximately 22% year over year to $387 million. Personal Care segment revenue in the fourth quarter of 2022 was $176 million, which was a 12% increase year over year.
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Modivcare Inc. More…
| Total Revenues | Net Income | Net Margin |
| 2.5k | -31.81 | -1.3% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Modivcare Inc. More…
| Operations | Investing | Financing |
| -10.44 | -111.81 | 3.81 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Modivcare Inc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.94k | 1.59k | 25.19 |
Key Ratios Snapshot
Some of the financial key ratios for Modivcare Inc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 18.4% | 32.2% | 2.3% |
| FCF Margin | ROE | ROA |
| -1.7% | 10.1% | 1.8% |
Market Price
On Thursday, MODIVCARE INC reported its earnings results for the fourth quarter of financial year 2022, ending December 31 2022. According to the report, the company’s stock opened at $103.2 and closed at $104.4, marking a 3.7% increase from its last closing price of $100.6. This was largely due to the company’s successful expansion into the international markets and its strategic partnerships with other industry leaders. MODIVCARE INC further announced that it had added 8 new products to its portfolio, which is a testament to the company’s commitment to innovation.
Overall, MODIVCARE INC’s stock performance, net income and product launches have all contributed to an impressive fourth quarter of financial year 2022 for the company. With this report, MODIVCARE INC has once again demonstrated why it is one of the leading companies in its industry. Live Quote…
Analysis – Modivcare Inc Intrinsic Value Calculator
At GoodWhale, we conducted an analysis of MODIVCARE INC‘s fundamentals. Our proprietary Valuation Line calculated the intrinsic value of MODIVCARE INC share to be around $160.1. Currently, MODIVCARE INC stock is traded at $104.4, which is undervalued by 34.8%. We believe this presents an attractive opportunity for investors who want to take advantage of the current market conditions and buy a good stock at a bargain price. More…
Peers
In the healthcare industry, there is intense competition between ModivCare Inc and its competitors: Humana AB, Mednax Inc, and Hanger Inc. These companies are all vying for a share of the market, and each has its own unique strengths and weaknesses. Humana AB is a large, international company that offers a wide range of services. Mednax Inc is a smaller company that specializes in maternal and child health. Hanger Inc is a publicly traded company that focuses on orthopedics.
– Humana AB ($LTS:0RF7)
Humana AB is a Swedish health insurance company with a market capitalization of 2.04 billion as of 2022. The company has a return on equity of 10.21%. Humana AB provides health insurance products and services to individuals, families, and businesses in Sweden. The company offers a range of health insurance products, including hospital, medical, and dental insurance. Humana AB also provides health and wellness services, such as health coaching and wellness programs.
– Mednax Inc ($NYSE:MD)
Mednax, Inc. is a national provider of maternal-fetal, newborn and pediatric clinical and anesthesia services. The Company operates through three segments: Physician Services, Ancillary Services and Other Services. The Company’s physician services include clinical care provided by its affiliated physicians and other clinicians to expectant mothers, newborn infants and pediatric patients in connection with their mothers’ pregnancies and deliveries, and neonatal intensive care unit (NICU) care. Ancillary services include diagnostic testing, pharmacy and ambulatory surgery center (ASC) operations. The Company’s other services include remote patient monitoring, patient engagement solutions and population health management services.
Summary
MODIVCARE INC reported strong earnings results for their fourth quarter of fiscal year 2022, with total revenue of USD -7.0 million and a net income of USD 653.9 million. Both figures showed significant growth when compared to the same quarter one year prior, indicating positive financial performance for the company. The market responded positively to the news and the stock price rose on the same day.
For potential investors, MODIVCARE INC is an attractive growth opportunity, with strong revenue and net income from the fourth quarter of fiscal year 2022 suggesting the company is in a good financial position. Investors should watch out for any further updates on the company’s earnings performance.
